Trial Profile
A study investigating the effect of bendamustine given as a first line therapy in patients from routine clinical practice with chronic lymphocytic leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Bendamustine (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms Be-CeLL1st
- 01 Dec 2015 New trial record